Company intelligence / Profile preview

Verio Therapeutics

Ottawa, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Verio Therapeutics advanced several preclinical biologic drug candidates focused on stimulation of endogenous stem cells for regenerating insulin-producing beta cells, muscle, and cardiac tissue. Programs were acquired and integrated by Fate Therapeutics.

Therapeutic areas: EndocrinologyCardiovascularMetabolic Disorders
Modalities: Biologic
Industry: Biotech

Beyond the preview

Go deeper on Verio Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Verio Therapeutics.

Explore the full profile